Bluebird Bio (BLUE) stock price, revenue, and financials

Bluebird Bio market cap is $1.4 b, and annual revenue was $250.73 m in FY 2020

$1.4 B

BLUE Mkt cap, 22-Oct-2021

$12.8 M

Bluebird Bio Revenue Q1, 2021
Bluebird Bio Gross profit (Q1, 2021)10.5 M
Bluebird Bio Gross profit margin (Q1, 2021), %82.2%
Bluebird Bio Net income (Q1, 2021)-205.8 M
Bluebird Bio EBIT (Q1, 2021)-231.2 M
Bluebird Bio Cash, 31-Mar-2021439.7 M
Bluebird Bio EV1.2 B
Get notified regarding key financial metrics and revenue changes at Bluebird BioLearn more
Banner background

Bluebird Bio Revenue

Bluebird Bio revenue was $250.73 m in FY, 2020 which is a 461.3% year over year increase from the previous period.

Embed Graph

Bluebird Bio Income Statement

Bluebird Bio Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

402.6m327.2m317.7m

Accounts Receivable

13.9m12.8m26.8m

Prepaid Expenses

19.8m32.9m37.5m

Current Assets

1.4b1.2b1.2b

PP&E

246.6m151.2m162.8m

Goodwill

13.1m13.1m13.1m

Total Assets

2.2b1.7b1.8b

Accounts Payable

17.8m43.0m21.6m

Short-term debt

20.2m25.0m

Current Liabilities

146.4m223.6m203.6m

Long-term debt

153.3m170.8m168.0m

Total Debt

153.3m191.0m193.0m

Total Liabilities

357.8m442.4m426.2m

Common Stock

547.0k554.0k665.0k

Additional Paid-in Capital

3.4b3.6b4.3b

Retained Earnings

(1.5b)(2.3b)(2.9b)

Total Equity

1.9b1.3b1.4b

Debt to Equity Ratio

0.1 x0.1 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x

Financial Leverage

1.2 x1.3 x1.3 x

Bluebird Bio Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

(555.6m)(789.6m)(618.7m)

Depreciation and Amortization

17.2m17.4m19.4m

Accounts Payable

3.6m23.6m(20.1m)

Cash From Operating Activities

(413.4m)(564.4m)(470.4m)

Purchases of PP&E

(55.7m)(71.0m)(29.0m)

Cash From Investing Activities

(679.4m)507.8m(84.3m)

Long-term Borrowings

(1.0m)

Cash From Financing Activities

737.7m21.2m546.7m

Net Change in Cash

(355.2m)(35.4m)(8.0m)

Interest Paid

15.5m

Income Taxes Paid

637.0k361.0k

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(164.4m)(360.2m)(566.3m)(202.6m)(224.1m)(418.8m)(205.8m)

Depreciation and Amortization

3.8m7.8m12.4m4.9m9.4m14.4m5.4m

Inventories

(7.1m)

Accounts Payable

10.6m6.7m23.3m(9.5m)(14.0m)(15.4m)67.0k

Cash From Operating Activities

(154.2m)(292.0m)(405.4m)(206.1m)(166.4m)(315.2m)(203.3m)

Purchases of PP&E

(19.3m)(37.9m)(58.6m)(10.7m)(15.5m)(21.1m)(7.6m)

Cash From Investing Activities

(36.9m)195.5m324.6m224.6m493.9m(233.2m)321.4m

Cash From Financing Activities

10.2m15.0m19.2m963.0k544.1m545.3m3.8m

Net Change in Cash

(180.8m)(81.5m)(61.7m)19.4m871.6m(3.0m)121.8m

Bluebird Bio Ratios

USDFY, 2018

EV/EBIT

-9 x

EV/CFO

-12.5 x

Revenue/Employee

96.8k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x

P/E Ratio

(9.3)

Bluebird Bio Operating Metrics

FY, 2018FY, 2019FY, 2020

Patents and Patent Applications

9361.17 k1.22 k

Bluebird Bio Human Capital

Job Roles

FY, 2020FY, 2019FY, 2018
General and Administrative 38.2%33.4%29.3%
Research and Development61.8%66.6%70.7%

Bluebird Bio Employee Rating

3.5157 votes
Culture & Values
3.7
Work/Life Balance
3.2
Senior Management
3.4
Salary & Benefits
3.9
Career Opportunities
3.5
Source